TSE:TMD - Titan Medical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started C$3.49 +0.14 (+4.18 %) (As of 05/20/2019 01:07 AM ET)Previous CloseC$3.49Today's RangeC$3.31 - C$3.4952-Week RangeC$1.44 - C$9.60Volume21,700 shsAverage Volume148,188 shsMarket CapitalizationC$108.71 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and general abdominal indications. Titan Medical Inc. is headquartered in Toronto, Canada. Receive TMD News and Ratings via Email Sign-up to receive the latest news and ratings for TMD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange TSE Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolTSE:TMD Previous Symbol CUSIPN/A CIKN/A Webwww.titanmedicalinc.com Phone416-548-7522Debt Debt-to-Equity RatioN/A Current Ratio1.17 Quick Ratio0.66Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.52 per share Price / Cash Flow6.70 Book ValueC$0.20 per share Price / Book17.90Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees9 Outstanding Shares31,150,000Market CapC$108.71 million Next Earnings Date8/12/2019 (Estimated) OptionableNot Optionable Titan Medical (TSE:TMD) Frequently Asked Questions What is Titan Medical's stock symbol? Titan Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TMD." When is Titan Medical's next earnings date? Titan Medical is scheduled to release their next quarterly earnings announcement on Monday, August 12th 2019. View Earnings Estimates for Titan Medical. Has Titan Medical been receiving favorable news coverage? Headlines about TMD stock have been trending somewhat positive on Monday, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Titan Medical earned a news impact score of 1.9 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days. Who are some of Titan Medical's key competitors? Some companies that are related to Titan Medical include Creo Medical Group (CREO), Medica Group (MGP), Hamilton Thorne (HTL), Advanced Oncotherapy (AVO), Cyclopharm (CYC), Impedimed (IPD), Helius Medical Technologies (HSM), Kromek Group (KMK), REVA Medical (RVA), Osprey Medical (OSP), Resonance Health (RHT), Protech Home Medical (PHM), Electromed (ELMD), Universal Biosensors (UBI) and Surgical Innovations Group (SUN). What other stocks do shareholders of Titan Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Titan Medical investors own include Titan Medical (TMDI), Aurora Cannabis (ACB), Walt Disney (DIS), MEG Energy (MEG), Capital Product Partners (CPLP), Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ), bluebird bio (BLUE), AeroVironment (AVAV), AtriCure (ATRC) and Advanced Micro Devices (AMD). Who are Titan Medical's key executives? Titan Medical's management team includes the folowing people: Mr. David J. McNally, Pres, CEO & Director (Age 57)Mr. Stephen D. Randall, CFO, Sec. & DirectorMr. Sachin A. Sankholkar, VP of MarketingDr. Bruce Giles Wolff, Sr. AdvisorDr. Perry A. Genova, Sr. VP of R&D How do I buy shares of Titan Medical? Shares of TMD and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Titan Medical's stock price today? One share of TMD stock can currently be purchased for approximately C$3.49. How big of a company is Titan Medical? Titan Medical has a market capitalization of C$108.71 million. Titan Medical employs 9 workers across the globe. What is Titan Medical's official website? The official website for Titan Medical is http://www.titanmedicalinc.com. How can I contact Titan Medical? The company can be reached via phone at 416-548-7522. MarketBeat Community Rating for Titan Medical (TSE TMD)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 10 (Vote Outperform)Underperform Votes: 7 (Vote Underperform)Total Votes: 17MarketBeat's community ratings are surveys of what our community members think about Titan Medical and other stocks. Vote "Outperform" if you believe TMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TMD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/20/2019 by MarketBeat.com StaffFeatured Article: What are defining characteristics of a correction? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.